Peer Reviewed Feature Articles
Obstructive airway diseases

COPD in Aboriginal and Torres Strait Islander Australians: a practical approach

Subash S. Heraganahally, Angus Lloyd, Simone Barry, Krishna B. Sriram, Lucy Burr

Chronic obstructive pulmonary disease (COPD) imposes a substantial burden on Aboriginal and Torres Strait Islander people. Assessment and management should take into account the considerable heterogeneity among this population, including sociodemographic factors, cultural beliefs and access to healthcare resources. 

Obstructive airway diseases

Inducible laryngeal obstruction: a deceptive mimic of asthma, anaphylaxis and other airway disorders

Paul Leong, Joy Lee, Adriana Avram, Anne E. Vertigan, Philip G. Bardin

Inducible laryngeal obstruction, also known as vocal cord dysfunction, is a common condition where the larynx narrows inappropriately, causing rapid onset of breathlessness and other symptoms. Delays in correct diagnosis, due to the condition’s similarity to asthma and other disorders, can mean that patients receive ineffective and sometimes harmful treatments. 

Respiratory infections

Influenza: how vaccine strains are selected each season

Ian G. Barr

Influenza viruses continually change to evade immunity, so vaccines must be regularly updated. This article outlines how WHO-led surveillance and assessment of circulating strains guide seasonal vaccine composition, highlighting key updates and evolving vaccine options for 2026.

Peer Reviewed Regular Series
Perspectives

Oral corticosteroids for COPD exacerbations – one size does not fit all

Lalitha Menon, Sanjay Ramakrishnan

The management of COPD exacerbations is entering a new era that moves towards tailored, evidence-based care. Recent studies show that eosinophil-guided therapy can safely reduce corticosteroid exposure in patients with COPD exacerbations without compromising recovery, even when used in the community setting.